pills on chemical structures

University of Minnesota Trial Shows Hydroxychloroquine Has No Benefit Over Placebo in Preventing COVID-19

June 3, 2020

Results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19 that were published in the New England Journal of Medicine determined that hydroxychloroquine was not able to prevent the development of COVID-19 any better than a placebo.

Other News

Virus closer look
On what do the experts agree? The omicron variant is one of the most transmissible viruses known.
virus illustrations and a question mark
I’m vaccinated, now what? First, thank you! Second, if you haven’t yet, schedule your booster shot.
planting
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…